# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Epidermal nevus

Keratinocytic nevusSebaceous nevus
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-7 of 7 results.
A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)
Status: Active, not recruiting
Last Changed: Aug 14, 2020
First Received: Mar 25, 2020
Disease(s): Epidermal Nevus Syndrome
Intervention(s): Crysvita (burosumab-twza) Treatment
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Status: Active, not recruiting
Last Changed: Jul 31, 2019
First Received: Mar 30, 2016
Disease(s): Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Intervention(s): KRN23
Locations: Osaka, Japan
Tokyo, Japan
Seoul, Korea, Republic of
Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Status: Active, not recruiting
Last Changed: Aug 10, 2020
First Received: Dec 01, 2014
Disease(s): Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS)
Intervention(s): Burosumab
Locations: Colorado Center for Bone Research at Panorama Orthopedics and Spine Center, Golden, Colorado, United States
Yale University School of Medicine, New Haven, Connecticut, United States
Indiana University Hospital, Indianapolis, Indiana, United States
Johns Hopkins University, Baltimore, Maryland, United States
Mayo Clinic, Rochester, Minnesota, United States
... and 3 other locations.
Burosumab for CSHS
Status: Active, not recruiting
Last Changed: Jan 28, 2020
First Received: Jun 21, 2019
Disease(s): Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS), Epidermal Nevus Syndrome
Intervention(s): Burosumab
Locations: Children's National Hospital, Washington, District of Columbia, United States
Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets
Status: Completed
Last Changed: Jan 18, 2020
First Received: Jul 10, 2018
Disease(s): Hypophosphatemia, Hypophosphatemic Rickets, Pain, Chronic
Intervention(s): Burosumab
Locations: The Focus Center, PC, Clinton, Utah, United States
Identification of Biomarkers for Patients With Vascular Anomalies
Status: Recruiting
Last Changed: Feb 05, 2020
First Received: Dec 22, 2016
Disease(s): Vascular Anomaly, Generalized Lymphatic Anomaly, Kaposiform Hemangioendothelioma, Kaposiform Lymphangiomatosis, Gorham-Stout Disease, Klippel Trenaunay Syndrome, Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi
Locations: Boston Children's Hospital, Boston, Massachusetts, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
National Registry for Ichthyosis and Related Disorders
Status: Unknown status
Last Changed: Apr 30, 2009
First Received: Dec 19, 2003
Disease(s): Darier Disease, Hailey-Hailey Disease, Hyperkeratosis, Epidermolytic, Ichthyosis, Ichthyosis, Lamellar, Ichthyosis, X-Linked, Keratoderma
Locations: University of Washington, Seattle, Washington, United States